CENVACIBART
UNII 6NM5PD4YTH

Substance Identification & Data

This profile provides standardized clinical and technical data for Cenvacibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6NM5PD4YTH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3008610-21-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6NM5PD4YTH
CAS Registry Number
3008610-21-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CENVACIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C214498
National Cancer Institute reference terminology for clinical and research data.
INN ID
13411
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cenvacibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CENVACIBART

Common Names & Synonyms

CENVACIBART [INN]
H-GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-445) (VH (HOMO SAPIENS IGHV3-11*01 (91.7%) -(IGHD) -IGHJ3*02 (100%), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10(CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 L92 (307) (229-338), CH3 (339-443), CHS (444-445)) (119-445)), (132-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (VKAPPA (HOMO SAPIENS IGKV1-33*01 (95.8%) -IGKJ2*02 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN BLOOD-COAGULATION FACTOR XI/XIA) (HUMAN MONOCLONAL REGN7508 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN7508 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS F11 (COAGULATION FACTOR 11, COAGULATION FACTOR XI, FXI, PLASMA THROMBOPLASTIN ANTECEDENT, PTA)), HOMO SAPIENS MONOCLONAL ANTIBODY

Technical Codes

REGN-7508

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus